2.99
price down icon3.24%   -0.10
after-market アフターアワーズ: 2.99
loading
前日終値:
$3.09
開ける:
$3
24時間の取引高:
50,930
Relative Volume:
0.66
時価総額:
$12.42M
収益:
-
当期純損益:
$-4.74M
株価収益率:
-3.9867
EPS:
-0.75
ネットキャッシュフロー:
$-3.46M
1週間 パフォーマンス:
+7.55%
1か月 パフォーマンス:
+21.54%
6か月 パフォーマンス:
+4.18%
1年 パフォーマンス:
-42.32%
1日の値動き範囲:
Value
$2.80
$3.10
1週間の範囲:
Value
$2.75
$3.1699
52週間の値動き範囲:
Value
$1.965
$12.00

Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile

Name
名前
Lipella Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
412-901-0315
Name
住所
400 N LEXINGTON ST, PITTSBURGH
Name
職員
7
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
LIPO's Discussions on Twitter

LIPO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LIPO
Lipella Pharmaceuticals Inc
2.99 12.42M 0 -4.74M -3.46M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Lipella Pharmaceuticals Inc (LIPO) 最新ニュース

pulisher
Jun 04, 2025

LIPO Secures Continued Partnership with Cook MyoSite for Enhanced Product Development | LIPO Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals Inc. Re-Signs Manufacturing Collaboration Agreement with Cook MyoSite Inc. to Support LP-310 Clinical Development - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Re-Signs Manufacturing Collaboration Agreement with Cook MyoSite - Contract Pharma

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals extends manufacturing pact with Cook MyoSite - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals Re-signs Manufacturing - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

First-Ever Oral Lichen Planus Treatment Advances as Lipella Secures Key Manufacturing Deal - Stock Titan

Jun 04, 2025
pulisher
May 19, 2025

Lipella Pharmaceuticals to appeal Nasdaq noncompliance warningPittsburgh Business Times - The Business Journals

May 19, 2025
pulisher
May 16, 2025

Lipella Pharmaceuticals Faces Nasdaq Compliance Challenge - TipRanks

May 16, 2025
pulisher
May 15, 2025

LIPO: Lipella Pharmaceuticals Reports Promising Phase 2a Trial Results for LP-310 | LIPO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Lipella Pharmaceuticals Presents Promising Phase 2a Trial Data - TipRanks

May 15, 2025
pulisher
May 15, 2025

Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Breakthrough Phase 2a Data: New LP-310 Treatment Cuts Oral Lichen Planus Pain by 65%, Exceeds Endpoints - Stock Titan

May 15, 2025
pulisher
Apr 23, 2025

Analytical Overview: Lipella Pharmaceuticals Inc (LIPO)’s Ratios Tell a Financial Story - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

Lipella Pharmaceuticals Abstract on Oral Lichen Planus - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Clinical Data: New Treatment Breakthrough for Oral Lichen PlanusPhase 2a Trial Shows Remarkable Improvement - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

LIPO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

LIPO stock’s current quarter earnings estimates: What analysts predict? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Reports Positive Results from Second Cohort in LP-310 Phase 2a Trial for Oral Lichen Planus - Reuters

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Pharmaceuticals announces results from second cohort of LP-310 trial - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Reports Positive Phase 2a Results from Second - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Clinical Trial Breakthrough: New Oral Lichen Planus Treatment Shows 65% Pain Reduction, Multiple Endpoint Success - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis - MarketBeat

Apr 17, 2025
pulisher
Apr 14, 2025

Lipella Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Lipella Pharmaceuticals regains Nasdaq compliance - Investing.com Australia

Apr 14, 2025
pulisher
Apr 10, 2025

Lipella Pharmaceuticals expands preferred stock class - Investing.com Australia

Apr 10, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals expands preferred stock class By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Clinical Trial Success: Lipella's Novel OLP Treatment Shows Encouraging Results in Phase 2a Study - Stock Titan

Apr 08, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Acquires Shares of 13,310 Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast - The Globe and Mail

Mar 31, 2025
pulisher
Mar 31, 2025

Clinical Trial Success: Lipella's 40-Year Veteran Shares Breakthrough Journey in Exclusive Interview - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Tariffs and Tech Troubles Weigh on Markets - The Globe and Mail

Mar 28, 2025
pulisher
Mar 28, 2025

Lipella Pharmaceuticals Inc. (LIPO) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

LIPELLA PHARMACEUTICALS INC. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 26, 2025

Analysts Are Bullish on Top Healthcare Stocks: Quince Therapeutics (QNCX), Lucid Diagnostics (LUCD) - The Globe and Mail

Mar 26, 2025
pulisher
Mar 13, 2025

Spartan Capital Securities, LLC Proudly Serves as the Sole Agent in Lipella Pharmaceuticals Inc. - Ukraine Business Journal

Mar 13, 2025
pulisher
Mar 08, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2.21 - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $3,788,000 Private Placement - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement - Yahoo Finance

Mar 04, 2025
pulisher
Mar 02, 2025

Lipella Pharmaceuticals (LIPO) Expected to Announce Earnings on Tuesday - Defense World

Mar 02, 2025

Lipella Pharmaceuticals Inc (LIPO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):